Researchers from Global Homoeopathy Foundation (GHF) in collaboration with scientists from Haffkine Institute, Mumbai have developed a new homoeopathic drug for TB patients from the germs causing the disease.

According Dr Rajesh Shah, secretary of GHF, the new medicine is sourced from current strains of tuberculosis, including the MDR TB. Medicines prepared from deadly germs can help treat many diseases and the method has been followed for years in developing vaccines. This is the first time that the germ-based drug is made applicable to TB and it is safe for human consumption.

To develop this new homoeopathy drug, Dr Rajesh Shah had teamed up with Dr Abhay Chowdhury, director of Haffkine Institute and finally succeeded in developing an effective drug under the homoeopathy stream of medicine.

In fact the process of developing this new homoeopathy drug is unique. The research team has followed most modern and scientific method to develop the new drug. The researchers are of the opinion that this drug will add value to the treatment of tuberculosis including multi-drug resistant tuberculosis (MDR-TB) patients.

Homoeopathic medicines prepared from many organisms including the bacteria and virus responsible for diphtheria, smallpox, measles, etc. are in practice long before the vaccines came into existence. Such homoeopathic medicines are called Nosodes. Interestingly, the medicines prepared from such organisms are safe to use and they are often used for conditions other than the original disease condition they are sourced from. For example, the medicine prepared from gonorrhea bacteria is often a great remedy for some varieties of asthma. “The new nosode prepared from the current strains of tuberculosis organisms is useful for improving the immune system of the patients, who may be prone to frequent respiratory infections. It will support the conventional treatment of tuberculosis and can be used along with the allopathic medicines,” said Dr Shah and quoted a study by the Central Council of Homoeopathy Research (CCRH) which demonstrated that homoeopathy and allopathic medicines used together produced better results than stand-alone method in tuberculosis cases.

Dr Shah is expected to present his research paper at the two-day World Homoeopathy Summit to be organized by the Global Homoeopathy Foundation in Mumbai on 11th of April this year. Homoeopaths and conventional doctors from across 25 countries are expected to participate in the event.

GHF is a non-government organization, conceptualized and formed by a group of conscientious, dedicated, apolitical, like-minded Indian professionals in early 2014. The main objective of GHF is to create a platform for homoeopathy to benefit the suffering humanity, assist the homoeopathy professionals in delivering proficient services and empower the growth of homoeopathy science in the world.